U.S., March 12 -- ClinicalTrials.gov registry received information related to the study (NCT06868758) titled 'Predictive Value of Tumor Vascular Normalization Scoring in HER-2 Positive Breast Cancer' on March 01.
Brief Summary: This study aims to evaluate the predictive value of the tumor vascular normalization score for the efficacy of neoadjuvant therapy in HER-2-positive breast cancer and explore its potential as a predictive biomarker. Through longitudinal observation of HER-2-positive breast cancer patients receiving standard treatment, we will analyze the correlation between vascular normalization scores and treatment responses (including objective response rate [ORR] and pathological complete response [pCR]) to optimize individualiz...